本文以典型国家DRG异化行为及其监管策略为研究对象,通过对国外文献、政策进行整理,总结德、美、英、日等DRG付费先行国家的DRG异化行为及其监管框架和管理机制,比较上述国家针对DRG异化行为监管遵循的基本原则和主要特征,探索国际DRG典型监管经验及对我国的启示,以期为国内DRG异化行为监管提供理论依据。
Abstract
This article takes the DRG alienation behavior and regulatory strategies of typical countries as the research object. By organizing foreign literature and policies, it summarizes the DRG alienation behavior, regulatory frameworks and management mechanisms of DRG payment countries such as Germany, the United States, the United Kingdom, and Japan. It compares the basic principles and main characteristics of DRG alienation behavior regulation in these countries, explores typical international DRG regulatory experience and enlightenment on China, in order to provide a theoretical basis for the regulation of DRG alienation behavior in China.
关键词
典型国家 /
DRG付费 /
异化行为 /
基金监管
Key words
typical countries /
DRG payment /
alienation behavior /
fund regulation
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] NEBY S, LAGREID P, MATTEI P, et al.Same cheat, different wrapping: DRG scandals and accountability in Germany and Norway[J].2013.
[2] 廖藏宜,张艺艺.DRG/DIP付费下异化行为表现及监管建议[J].中国医疗保险,2023(02):27-34.
[3] 廖藏宜,刘彬.医保DRG与DIP付费方式的差异比较[J].中国医院院长,2022,18(08):77-81.
[4] RICE T, ROSENAU P, UNRUH L Y, et al.United States of America: health system review[J].2013.
[5] LAUTERBACH K, LUNGEN M.DRG-Fallpauschalen: eine Einführung: Anforderungen an die Adaption von Diagnosis-related groups in Deutschland; Gutachten im Auftrag des AOK-Bundesverbandes[M].Schattauer, 2001.
[6] GAY E G, KRONENFELD J J.Regulation, retrenchment—the DRG experience: problems from changing reimbursemwnt practice[J].Social science and medicine,1990,31(10):1103-1118.
[7] REAMER F G.Facing up to the challenge of DRGs[J].Health and social work,1985,10(2):85-94.
[8] JOHNSON D, DAYAL G, SMITH J.40 years in the payment reform wilderness: DRGs to nirvana[J].2017.
[9] BUSSE R,QUENTIN W.Moving towards transparency, efficiency and quality in hospitals: conclusions and recommendations[J].Diagnosis related groups in Europe: moving towards transparency, efficiency and quality in hospitals,2011:149-174.
[10] ANNEAR P L, KWON S, LORENZONI L, et al.Pathways to DRG-based hospital payment systems in Japan, Korea, and Thailand[J].Health policy,2018,122(7):707-713.
[11] World Health Organization.Case-based payment systems for hospital funding in Asia: an investigation of current status and future directions[J].2015.
[12] 郝春彭,谭中和.中国医疗保障基金监督管理发展报告(2021)[M].北京:社会科学文献出版社,2021:190-198.
[13] KWON S, SHON C.Implementation experience with DRG-based payments[J].Case-based payment systems for hospital funding in Asia: an investigation of current status and future directions,2015:54.
[14] HASELTINE W A.Affordable excellence: the Singapore healthcare story: how to create and manage sustainable healthcare systems[M].Brookings Institution Press, 2013.
[15] KAZLEY A S,OZCAN Y A.Do hospitals with electronic medical records (EMRs) provide higher quality care? An examination of three clinical conditions[J].Medical care research and review,2008,65(4):496-513.
[16] SAKAMOTO H, RAHMAN M, NOMURA S, et al.Japan health system review[J].Health systems in transition,2018,8(1).
[17] Audit Commission.Payment by results assurance framework.Pilot results and recommendations.7 December 2006[J].2008.
[18] Audit Commission for Local Authorities and the National Health Service in England and Wales.Improving data quality in the NHS: annual report on the PbR assurance programme[M].Audit Commission,2010.
[19] BLUMEL M, SPRANGER A, ACHSTETTER K, et al.Germany: Health system review[J].2020.
[20] BOYLE S, HUTTON J, STREET A, et al.Introducing activity-based funding to financial flows between providers and commissioners in Northern Ireland.Draft report for McClure Watters[J].2007.
[21] BUSSE R,RIESBERG A,World Health Organization.Health care systems in transition:Germany[J].2004.
[22] SINHA G.Governments move to improve quality and cut costs[J].2007.
[23] MATSUDA R.The Japanese health care system[J].International profiles of health care systems,2020:127.
[24] LIM M K.Quest for quality care and patient safety: the case of Singapore[J].BMJ quality & safety,2004,13(1):71-75.
[25] MCAUSLANE N,CONE M, COLLINS J, et al.Emerging markets and emerging agencies: a comparative study of how key regulatory agencies in Asia, Latin America, the Middle East, and Africa are developing regulatory processes and review models for new medicinal products[J].Drug information journal,2009,43(3):349-359.
[26] BUSSE R,GEISSLER A, AAVIKSOO A, et al.Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals?[J].BMJ,2013,346.
[27] FALCON-LAW M M, GRIFFIN P, PERALES I N, et al.Aspects of American HealthCare:CMS and the RAC[C].The 67th International Atlantic Economic Conference.
[28] CMS.Medicare NCCI FAQ Library.[EB/OL].(2022-07-01)[2023-03-24].https://www.cms.gov/medicare-medicaid-coordination/national-correct-coding-initiative-ncci/ncci-medicare/medicare-ncci-faq-library#manual.
[29] CMS.Approved RAC Topics.[EB/OL].(2017-02-01)[2023-03-24].https://www.cms.gov/Research-Statistics-Data-and-Systems/Monitoring-Programs/Medicare-FFS-Compliance-Programs/Recovery-Audit-Program/Approved-RAC-Topics.
[30] CMS.Medicare Fee for Service Recovery Audit Program[EB/OL].(2017-09-09)[2023-03-24].https://www.cms.gov/research-statistics-data-and-systems/monitoring-programs/medicare-ffs-compliance-programs/recovery-audit-program.
[31] CMS.Part D RAC Audit Process[EB/OL].(2012-04-12)[2023-03-24].https://www.cms.gov/data-research/monitoring-programs/part-c-d-recover-audit-program/part-d-rac-audit-process.
[32] MIHAILOVIC N, KOCIC S, JAKOVLJEVIC M.Review of diagnosis-related group-based financing of hospital care[J].Health services research and managerial epidemiology,2016,3:2-6.
[33] 陈双慧,肖馨怡,吴海波.DRG改革背景下负向医疗行为的成因分析及治理策略[J].医学与哲学,2022,43(20):37-40.
基金
国家自然科学基金青年科学基金项目“价值医保视域下DRG付费改革的效果评价及政策优化研究”（72004235）; 首都医科大学国家医疗保障研究院开放性课题“基于DRG/DIP支付方式改革的基金监管方式创新研究”（YB2022B16）
